Genexine has laid down a marker in its bid to challenge for the chronic kidney disease (CKD)-induced anemia field, showing that its investigational drug candidate matched Roche and CSL Vifor’s Mircera ...
SEOUL, South Korea--(BUSINESS WIRE)--A clinical-staged proprietary platform technology biotech company Genexine (KQ 095700, CEO Neil Warma) and its Asian regional partner, KG Bio unveiled the interim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback